|186.17||-0.9500||-0.51%||Vol 7.33K||1Y Perf 8.24%|
|Dec 3rd, 2021 15:50|
|Price Range Ratio 52W %||54.22||Managed Assets (in ths.)||375.44K|
Today's Price Range
|Moving Averages:||Strong Sell|
The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.
|Avg. Weekly Volume||5.67K|
|Avg. Monthly Volume||5.31K|
|Avg. Quarterly Volume||5.11K|
|Dividends & Splits|
|Dividend Date||24th Sep 2021|
|Dividend Rate Ann.||2.71|
|Dividend Yield Ann.||1.45|
|Fundamentals & Details|
|Managed Assets (in ths.)||375.44K|
|First Trade Price||50.16|
|Fund Family||BlackRock iShares|
|Underlying Index||Dow Jones ...|
|Inception Date||1st May 2006|
|Equity Specialty Type||-|
|Total Holdings Count||52|
|Top 1||PFE||Pfizer Inc.||22.56%|
|Top 2||JNJ||Johnson & Johnson||21.40%|
|Top 3||RPRX||Royalty Pharma plc||4.92%|
|Top 4||ZTS||Zoetis Inc. Class A||4.92%|
|Top 5||LLY||Eli Lilly and Company||4.60%|
|Top 6||MRK||Merck & Company Inc. (new)||4.58%|
|Top 7||CTLT||Catalent Inc.||4.33%|
|Top 8||ELAN||Elanco Animal Health Incorporated||4.10%|
|Top 9||VTRS||Viatris Inc.||3.96%|
|Top 10||BMY||Bristol-Myers Squibb Company||3.88%|
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.